Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
44 Leser
Artikel bewerten:
(0)

Dry Eye Drugs Price Analysis and Strategies 2012-2021: Identify How Drugs are Clinically and Commercially Positioned - Research and Markets

DUBLIN, Feb 24, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Dry eye Drugs Price Analysis and Strategies - 2016" report to their offering.

The latest research Dry eye Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Dry eye market.

The research answers the following questions:

  • What are the key drugs marketed for Dry eye and their clinical attributes? How are they positioned in the Global Dry eye market?
  • What are the unit prices and annual treatment cost for Dry eye therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
  • What are the unmet needs in the global Dry eye drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Dry eye?

Research Scope:

  • Dry eye Treatment Options - Identify key drugs marketed and prescribed for Dry eye in the US, Germany, France, Italy, Spain, UK, Japan including trade name, molecule name, and company
  • Dry eye Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Dry eye
  • Market Positioning - Identify how drugs are clinically and commercially positioned in the global Dry eye market
  • Dry eye Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed for Dry eye in the US, Germany, France, Italy, Spain, UK, Japan. Find out how the price advanced from 2012 and forecast to 2021
  • Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape in the US, Germany, France, Italy, Spain, UK, Japan
  • Dry eye New Drug Pricing - Identify the effective pricing strategy for a new drug launch in the US, Germany, France, Italy, Spain, UK, Japan

This research will help executives

  • Identify clinical attributes of your competitor drugs
  • Find out how the marketed products for Dry eye are clinically and commercially positioned
  • Understand the price of your competitor drugs by countries
  • Use Dry eye drugs price data for market sizing, drug sales forecast, budgeting, competitive intelligence, HEOR, and reimbursement
  • Find out the pricing and reimbursement landscape by countries
  • Identify the unmet need in global Dry eye market
  • Identify the effective pricing for a new drug

For more information about this report visit http://www.researchandmarkets.com/research/fkh646/dry_eye_drugs

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.